06-23 Saniona: Our take on the SAN2668 R&D day AQ
06-17 Saniona AB - Special Call
06-11 Three shots on goal: Saniona prepares to enter the clinic AQ
06-04 Saniona to Host Virtual R&D Day Focusing on SAN2668 for Severe Pediatric Epilepsies AQ
05-28 Saniona (Q1 Review): Setting up for the long run AQ
05-28 Redeye raises fair value for Saniona to SEK 20 (19) FW
05-27 Bulletin from the Saniona AB annual shareholders’ meeting on May 27, 2026 AQ
05-27 Voleon Capital no longer a public short seller in Saniona FW
05-26 Saniona AB Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-26 Saniona AB, Q1 2026 Earnings Call, May 26, 2026
05-26 Saniona Q1 revenue SEK 4.6 mln RE
05-26 Saniona reports widening operating loss FW
05-26 SANA : Interim Report Q1 2026 PU
05-26 Saniona publishes its interim report for the first quarter of 2026 AQ
05-22 Syria signs deal with CMA CGM to operate two dry ports, state media says RE
05-20 Invitation to Saniona Q1 investor call on 26 May 2026 AQ
05-12 Islamic State claims deadly attack on Syrian government forces RE
04-30 Saniona publishes its Annual Report for 2025 AQ
04-27 SANA : The board's statement pursuant to Chapter 19, Section 22 of the Swedish companies Act PU
04-24 SANA : Notice of annual shareholders' meeting 2026 PU
04-24 SANA : Proposal for resolution on LTI 2026 PU
04-24 SANA : Notice of Saniona AB annual shareholders' meeting PU
04-24 Notice of Saniona AB annual shareholders’ meeting AQ
04-07 Neurocrine to acquire Soleno in multi-billion dollar deal FW
03-30 Syrian army says drone attacks targeted bases near Iraqi border, studying response options RE
No results match your criteria